论文部分内容阅读
目的:探究不同类型肠易激综合征患者治疗成效。方法:80例不同类型肠易激综合征患者,随机分组,对照组为培菲康治疗,观察组为黛力新联合培菲康治疗。比较临床治疗有效率、不良反应发生情况。结果:在临床治疗效果方面,观察组治疗总有效率95%,对照组总有效率75%;不良反应发生情况,观察组为7.5%,对照组为25%。结论:不同类型肠易激综合征患者治疗过程中通过黛力新与培菲康联合治疗后取得的临床成效显著。
Objective: To investigate the treatment effect of different types of irritable bowel syndrome patients. Methods: Eighty patients with different types of irritable bowel syndrome were randomly divided into two groups. The control group was treated with Pefikan and the observation group was Deanxit. Comparison of clinical treatment efficiency, adverse reactions occurred. Results: In the clinical treatment effect, the total effective rate of the observation group was 95%, the total effective rate of the control group was 75%. The incidence of adverse reactions was 7.5% in the observation group and 25% in the control group. Conclusion: The clinical efficacy of different combinations of patients with irritable bowel syndrome treated by combination of Deanxit and Baclofen is significant.